We have a long history of responding to crises, in the UK and around the world and are leaders in emergency vaccine development. During the 2014 Ebola outbreak, our scientists performed the world’s first human Ebola vaccine studies, starting them before any other university or company. Our researchers, in collaboration with partners across the globe, are working to develop an effective vaccine and drugs to target this virus, and have already introduced innovative public health measures and collaborative online tools that are being used in hospitals here and abroad.
Read more about how Oxford Medical Sciences is fighting Coronavirus (University of Oxford Medical Sciences website)
Funding for Oxford’s COVID-19 research requires unprecedented speed, scope and ambition. Please make a gift >>